Literature DB >> 25471318

Effect of levitra on sustenance of erection (EROS): an open-label, prospective, multicenter, single-arm study to investigate erection duration measured by stopwatch with flexible dose vardenafil administered for 8 weeks in subjects with erectile dysfunction.

Y S Shin1, S W Lee2, K Park3, W S Chung4, S W Kim5, J S Hyun6, D G Moon7, S-K Yang8, J K Ryu9, D Y Yang10, K H Moon11, K S Min12, J K Park1.   

Abstract

To investigate the change of erection duration measured by stopwatch with flexible dose vardenafil administered for 8 weeks in subjects with erectile dysfunction (ED). Effect of levitra on sustenance of erection was an open-label, prospective, multicenter and single-arm study designed to measure the duration of erection in men with ED receiving a flexible dose of vardenafil over an 8-week treatment period. Patients were instructed to take vardenafil 10 mg 60 min before attempting the intercourse. Vardenfil could be increased to 20 mg or decreased to 5 mg concerning patients' efficacy and safety. Following the initial screening, patients entered a 4-week treatment-free run-in phase and 8-week treatment period, during which they were instructed to attempt intercourse at least four times on four separate days. A total of 95 men were enrolled in 10 centers. After the 8 weeks treatment, the mean duration of erection leading to successful intercourse was statistically superior when patients were treated with vardenafil. After an 8-week treatment, the duration of erection leading to successful intercourse was 9.39 min. There were significant benefits with vardenafil in all domains of International Index of Erectile Function. Secondary efficacy end points included success rate of penetration, maintaining erection, ejaculation and satisfaction were superior when patients were treated with vardenafil. There was a significant correlation between duration of erection with other sexual factors. Also partner's sexual satisfaction was increased with vardenafil. Most adverse events were mild or moderate in severity. Vardenafil was safe and well tolerated. Vardenafil therapy provided a statistically superior duration of erection leading to successful intercourse in men with ED with female partner.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25471318     DOI: 10.1038/ijir.2014.39

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  17 in total

1.  Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial.

Authors:  Wayne J G Hellstrom; Marc Gittelman; Gary Karlin; Thomas Segerson; Marc Thibonnier; Terry Taylor; Harin Padma-Nathan
Journal:  J Androl       Date:  2002 Nov-Dec

2.  Impact of erectile dysfunction (ED) on sexual life of female partners: assessment with the Index of Sexual Life (ISL) questionnaire.

Authors:  Marie Chevret; Eric Jaudinot; Kate Sullivan; Alexia Marrel; Anne Solesse De Gendre
Journal:  J Sex Marital Ther       Date:  2004 May-Jun

3.  Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study.

Authors:  Raymond Rosen; Ridwan Shabsigh; Mark Berber; Pierre Assalian; Mathew Menza; Luis Rodriguez-Vela; Robert Porto; Keith Bangerter; Monica Seger; Francesco Montorsi
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

4.  Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study.

Authors:  William A Fisher; Raymond C Rosen; Ian Eardley; Michael Sand; Irwin Goldstein
Journal:  J Sex Med       Date:  2005-09       Impact factor: 3.802

5.  Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil.

Authors:  William A Fisher; Raymond C Rosen; Martin Mollen; Gerald Brock; Gary Karlin; Peter Pommerville; Irwin Goldstein; Keith Bangerter; Tiemo-Joerg Bandel; Leonard R Derogatis; Michael Sand
Journal:  J Sex Med       Date:  2005-09       Impact factor: 3.802

6.  Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): a randomized, double-blind, placebo-controlled trial in PDE5 inhibitor-naïve men with ED and their partners.

Authors:  David Edwards; Geoff Hackett; Owen Collins; John Curram
Journal:  J Sex Med       Date:  2006-11       Impact factor: 3.802

7.  Improvement in erectile function on vardenafil treatment correlates with treatment satisfaction in both patients and their partners.

Authors:  David Ralph; Ian Eardley; Philip Kell; John Dean; Geoff Hackett; Owen Collins; David Edwards
Journal:  BJU Int       Date:  2007-05-04       Impact factor: 5.588

Review 8.  NIH Consensus conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake.

Authors: 
Journal:  JAMA       Date:  1994-12-28       Impact factor: 56.272

9.  Vardenafil in men with stable statin therapy and dyslipidemia.

Authors:  Martin Miner; Larry Gilderman; James Bailen; David Cook; Katie Dawson; Marisha Stanislaus; Eric Beresford; Allison Barnes
Journal:  J Sex Med       Date:  2008-03-26       Impact factor: 3.802

10.  Vardenafil improves erectile function in men with erectile dysfunction and associated underlying conditions, irrespective of the use of concomitant medications.

Authors:  Ian Eardley; Jay C Lee; Ridwan Shabsigh; John Dean; Mario Maggi; Dieter Neuser; Christiane Norenberg
Journal:  J Sex Med       Date:  2010-01       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.